ATLANTA -- Inviro Medical Devices announces that it has entered into a new agreement with Premier Purchasing Partners, LP that provides members of the Premier alliance access to Inviro's extensive portfolio of InviroSNAP!® Safety Syringe products. The agreement was awarded as part of Premier's Technology Breakthroughs Program and starts May 1, 2007.Â
"Premier's process for assessing new technologies is thorough, rigorous and demanding," says Jim Charlesworth, senior vice president of sales for Inviro Medical Devices. "We are delighted, but not surprised, that our InviroSNAP! products have successfully passed through this process, and we look forward to presenting our comprehensive range of safety syringes to Premier members."
"The contract with Premier may help to further enhance our market position as we aggressively roll out the Inviro Safety System in the U.S. and Canada," says Gareth Clarke, chief executive officer of Inviro Medical Devices. "As the second major GPO contract we have secured during 2007, this agreement represents yet another significant milestone for our company. It is a clear recognition that we offer healthcare facilities a unique alternative to their existing safety syringe technology."
Inviro Medical Devices engineers and markets safe medication delivery systems, including the patented InviroSNAP! Safety Syringe. After years of research to develop patents and refine product designs, the company is addressing the growing $1.6 billion safety syringe market and introducing its breakthrough infection control technology in North America to help address employee and patient safety concerns.Â
Source: Inviro Medical Devices
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.